Hunan Pinsheng Biotechnology Co., Ltd. was established in 2017. It is a high-tech enterprise focusing on the research and development of early tumor screening technology and medical data integration platform. The company is committed to the application of fully automatic microscopy platform and artificial intelligence in the medical field, and provides tumor detection equipment, in vitro diagnostic reagents and medical software systems that integrate research and development, manufacturing, sales and services. The company has gathered a large number of outstanding talents at home and abroad, established a research and development team led by postdoctoral students in the United States, created a technical innovation platform with “fully automatic microscopy platform + medical artificial intelligence” as the core, and developed a full set of cervical cancer screening cell DNA quantification system. At present, more than 100 national patents have been applied for.

The company has a modern office, equipped with high-precision automated production lines, national standard 10,000-level laboratories and 100,000-level purification production workshops, and has successively passed ISO13485, CE certification and GMP certification. The company adheres to the corporate purpose of “protecting life and pursuing excellence”, takes saving the world as its own responsibility, takes talents as the core, and takes the market as the orientation, creating long-term and sustainable value growth for customers, and going all out for human anti-cancer and health.